A Randomized, Double-blind, Active-and Placebo-controlled Phase 3 Study of Efficacy and Safety of Ixekizumab, Adalimumab, and Placebo Therapy in Patients Naive to Biologic Disease Modifying Antirheumatic Drugs with Active Psoriatic Arthritis
Author(s):
Mease, P.; Heijde, D. van der; Ritchlin, C.; Cuchacovich, R.; Shuler, C.; Lin, C.Y.; Vangerow, H.; Samanta, S.; Lee, C.; Gladman, D.
Published
2016
Publication type
Article / Letter to editor
Date issued
2016-06-30
Language
English
Is part of
Journal of Rheumatology (2016), Vol. 43, no. 6, p. 1169-1169
